Cooperative Agreement NU2HJG000016
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $837,589 Cooperative Agreement to the Ministere De La Sante Et De L'Action Social in Senegal under the CDC Investigations and Technical Assistance program (CFDA 93.283). The funding supports a range of public health initiatives focused on controlling communicable diseases, chronic diseases, and other preventable health conditions through research, surveillance, epidemiological investigations, and technical assistance. The 5-year...
- This Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283), provides $265,000.00 in funding to the Direction Of Disease Control, Epidemics And Pandemics in Cameroon. The purpose of this 5-year award, with a start date of September 30, 2025 and a completion date of September 29, 2030, is to protect and improve public health globally by building and strengthening public health impact system...
- This $587,500 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports efforts by the Cameroon Baptist Convention Health Board to strengthen public health laboratory systems in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The award period runs from October 2024 through September 2027. Key activities include implementing comprehensive HIV services, strengthening laboratory...
- The Department of State's Bureau of African Affairs awarded a $250,000 cooperative agreement to Miscellaneous Foreign Awardees under the Regional Peace and Security federal grant program (CFDA 19.979) to foster dialogue, intercommunal trust, and a stronger sense of national identity in areas at risk of destabilization in Côte d'Ivoire. The agreement period is from September 30, 2022 through September 30, 2023. Through this funding, Miscellaneous Foreign Awardees will provide services and...
- This five-year $1,355,000 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) aims to enhance the capacity of Central America and the Dominican Republic to prevent, detect, and respond to infectious disease threats. The initiative will strengthen regional leadership, technical capacity, and multi-sectoral collaboration to address cross-border infectious disease challenges. The primary...
- This $31,683,613 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports the Cameroon Baptist Convention Health Board (CBCHB) in Cameroon to develop, implement, and sustain high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults under the President's Emergency Plan for AIDS Relief (PEPFAR). The award period is from October 24, 2024 to September 29,...
- The Centers for Disease Control and Prevention (CDC) awarded a $750,000 Cooperative Agreement to the National Institute of Health (NIH) in Pakistan under the CDC Investigations and Technical Assistance program (CFDA 93.283). The 5-year project, running from September 2025 to September 2030, aims to build public health personnel capacity, expand global health security efforts, and develop robust systems for detecting, preventing, and responding to infectious disease outbreaks in Pakistan. The...
- The Association of Public Health Laboratories, Inc. (APHL) was awarded a $2,390,311 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) to enhance public health laboratory capabilities and capacities. The award has a performance period from July 1, 2025 to June 30, 2030. Through this funding, APHL will support efforts to strengthen public health laboratory infrastructure, develop innovative health...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $279,270 Project Grant to Advanced Virology Inc. in Philadelphia, PA on September 30, 2025. The grant, funded through the CDC's Investigations and Technical Assistance program (CFDA 93.283), supports the development of "LOW-COST AND HIGH EFFICIENCY DNA-BASED REVERSE GENETICS PLATFORMS FOR MANUFACTURING RNA VIRUS PRODUCTS." The project aims to advance technologies for the production of RNA virus-based products through...
- This Cooperative Agreement award, valued at $225,000.00, was provided by the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention through the Global AIDS Federal Grant Program (CFDA 93.067). The award is intended to support comprehensive efforts to combat HIV/AIDS globally through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). The primary objectives are to prevent new HIV infections, expand access to treatment, strengthen health systems, and...
The Centers for Disease Control and Prevention (CDC) awarded a $650,000 cooperative agreement to the Pasteur Institute of Ivory Coast (Institut Pasteur De Cote D'Ivoire) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The five-year award, effective from September 30, 2025 to September 29, 2030, aims to strengthen public health laboratory systems for priority disease detection and outbreak surveillance in Côte d'Ivoire. The Pasteur Institute, a non-profit organization based in Abidjan, will leverage its expertise in laboratory diagnostics, disease surveillance, and public health system strengthening to support this initiative. The award reflects the institute's core competencies and prior experience in federal grants, including sub-awards focused on building laboratory capacity for HIV-related opportunistic infections and supporting community-based HIV services in Côte d'Ivoire.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $650.0k | 9/8/25 |